These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 5048217

  • 1. Treatment of mycosis fungoides with topical nitrosourea compounds.
    Zackheim HS.
    Arch Dermatol; 1972 Aug; 106(2):177-82. PubMed ID: 5048217
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
    Zackheim HS, Epstein EH.
    Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
    [Abstract] [Full Text] [Related]

  • 3. Topical lomustine in the treatment of psoriasis.
    Peck GL, Guss SB, Key DJ.
    Arch Dermatol; 1972 Aug; 106(2):172-6. PubMed ID: 4558698
    [No Abstract] [Full Text] [Related]

  • 4. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract] [Full Text] [Related]

  • 5. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW, Humphrey EW.
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract] [Full Text] [Related]

  • 6. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
    Olshin S, Siddiqui S, Firat D.
    Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of malignant brain tumors with nitrosoureas.
    Hansen HH, Muggia FM.
    Cancer Chemother Rep; 1971 Apr; 55(2):99-100. PubMed ID: 4330275
    [No Abstract] [Full Text] [Related]

  • 15. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG, Laster WR, Andrews CM, Schabel FM.
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract] [Full Text] [Related]

  • 16. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB, Boldrey EB, Enot KJ.
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structure-activity relationships: nitrosoureas.
    Johnston TP.
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract] [Full Text] [Related]

  • 20. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB, Falkson HC, Falkson G.
    Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.